Korean J Lab Med.  2004 Feb;24(1):27-32.

Cystatin C as a Marker for Early Renal Impairment

Affiliations
  • 1Department of Laboratory Medicine, Keimyung University College of Medicine, Daegu, Korea. ksksmom@dsmc.or.kr
  • 2Department of Internal Medicine, Keimyung University College of Medicine, Daegu, Korea.
  • 3Department of Diagnostic Laboratory Medicine, Sungkyunkwan University College of Medicine, Masan Samsung Hospital, Masan, Korea.

Abstract

BACKGROUND
In recent years, cystatin C was proposed as a new marker for the glomerular filtration rate due to a constant serum level, with no secretion from the renal tubule, and elimination only by the kidneys. The aim of this study was to evaluate cystatin C as a renal marker compared with creatinine. METHODS: The concentration of serum creatinine, cystatin C, and creatinine clearance were measured in 119 healthy adults and 112 patients with several nephropathies. RESULTS: The reference interval of cystatin C was 0.45-0.96 mg/L and there were no significant correlations to age, sex and bodysurface area (P>0.05). Cystatin C and creatinine were highly correlated with the glomerular filtration rate measured by creatinine clearance (r=0.810, 0.806, respectively). Diagnostic accuracy by receiver- operation characteristic curves were similar (area under the curve, cystatin C 0.853 vs. creatinine 0.882). But cystatin C showed greater sensitivity for detecting a decreased glomerular filtration rate than did creatinine (82%, 76% respectively). Especially, the sensitivity of cystatin C was higher than that of creatinine in mildly decreased groups when patients were classified into four groups according to the decrement of the glomerular filtration rate. CONCLUSIONS: Serum cystatin C is as useful as serum creatinine as a renal marker and is superior as a screening marker in detecting early renal impairment.

Keyword

Cystatin C; Early renal impairment; Renal marker

MeSH Terms

Adult
Creatinine
Cystatin C*
Glomerular Filtration Rate
Humans
Kidney
Mass Screening
Creatinine
Cystatin C
Full Text Links
  • KJLM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr